Evidence map›Paper›PMID 31186664›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2019

Kangquan Recipe Regulates the Expression of BAMBI Protein via the TGF-

Wenfan Chen, Xiaoqing Huang, Axiang Peng, Tingting Chen, Renzhi Yang, Yuanpeng Huang, Zongbao Yang, Shengyan Xi

Open access · hybridAbstract read
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Efficacy of Buzhong Yiqi decoction on benign prostatic hyperplasia and its possible mechanism.Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan · 2023
    Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Wenfan ChenDepartment of Traditional Chinese Medicine, Zhongshan Hospital, Xiamen University, Xiamen 361004, Fujian Province, China.
Xiaoqing HuangDepartment of Traditional Chinese Medicine, Zhongshan Hospital, Xiamen University, Xiamen 361004, Fujian Province, China.
Axiang PengDepartment of Traditional Chinese Medicine, Zhongshan Hospital, Xiamen University, Xiamen 361004, Fujian Province, China.
Tingting ChenDepartment of Traditional Chinese Medicine, School of Medicine, Xiamen University, Xiamen 361102, Fujian Province, China.
Renzhi YangDepartment of Traditional Chinese Medicine, Zhongshan Hospital, Xiamen University, Xiamen 361004, Fujian Province, China.
Yuanpeng HuangDepartment of Traditional Chinese Medicine, Zhongshan Hospital, Xiamen University, Xiamen 361004, Fujian Province, China.ORCID 0000-0002-2584-6729
Zongbao YangDepartment of Traditional Chinese Medicine, School of Medicine, Xiamen University, Xiamen 361102, Fujian Province, China.
Shengyan XiDepartment of Traditional Chinese Medicine, School of Medicine, Xiamen University, Xiamen 361102, Fujian Province, China.ORCID 0000-0002-8315-6742
Xiamen University · CNZhongshan Hospital of Xiamen University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundKangquan Recipe (KQR) is a traditional Chinese medicine compound made by our research group for the treatment of benign prostatic hyperplasia (BPH). Whether KQR can treat BPH as a single drug or play a role in the treatment of BPH in combination therapy needs further study. AIM OF THE STUDY: To investigate the effect of KQR on the expression of TGF- MATERIALS AND

methodsForty-eight male Sprague-Dawley rats were randomly divided into six groups of 8 rats each. In addition to the control group, 40 rats were castrated and then injected with testosterone propionate to form a prostatic hyperplasia model. After 30 days, three groups received different concentrations of KQR (14 g/kg, 7 g/kg, and 3.5 g/kg), and the finasteride group received 0.5 mg/kg finasteride. The BPH group and the control group received the same volume of saline. All groups were treated for a total of 30 days. Rat body weight, prostate volume, wet weight, index, histology, and the mRNA and protein levels of TGF-

resultsCompared with the control group, the BPH group had increased prostate wet weight, volume, and index, and the histology showed significant BPH. Compared with the BPH group, the three KQR groups and the finasteride group all had varying levels of reduction in the prostate wet weight, volume, and index of the prostate and varying degrees of improvement in the histological manifestations of BPH. KQR downregulates the mRNA and/or protein expression of TGF-

conclusionsIn the model of BPH induced by testosterone propionate after castration, KQR can inhibit the conduction of the TGF-

Identifiers

PMID31186664
PMCPMC6521302
OpenAlexW2943667383

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.